Bacterial Meningitis in Cirrhotic Patients:Case Series and Description of the Prognostic Role of Acute Renal Failure

Journal of Clinical Gastroenterology

Volumn 44, Issue 9, 2010, Pages e218-e223

  Barahona Garrido, Josué ^a   Hernández Calleros, Jorge ^a   Téllez Ávila, Félix I ^b   Chávez Tapia, Norberto C ^b   Remes Troche, José M ^b   Torre, Aldo ^c  

^a Instituto de Enfermedades Digestivas y Nutricionales   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c SSA   (Mexico)

Author keywords

Acute renal failure; Central nervous system diseases; Guatemala; Infection; Liver cirrhosis; Meningitis; Mexico; Prognosis

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; BACTERIAL MENINGITIS; BILIRUBIN BLOOD LEVEL; BLOOD CULTURE; BLOOD LEVEL; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CREATININE BLOOD LEVEL; CYTOLOGY; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; LISTERIA MONOCYTOGENES; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; MUSCLE STIFFNESS; PATIENT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS BOVIS; STREPTOCOCCUS PNEUMONIAE;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; CREATININE; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 77957588919     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181d88d53     Document Type: Article

References (46)

1. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140-148.
2. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicenter prospective study. Digest Liver Dis. 2001;33:41-48.
3. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26-42.
4. Deschenes M, Villeneuve JP. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol. 1999;94:2193-2197.
5. López-Arce G, Torre-Delgadillo A, Téllez-Avila FI. Salmonella sp group A: a rare cause of bacterascites. A case report. Ann Hepatol. 2008;7:260-261.
6. Chavez-Tapia NC, Torre-Delgadillo A, Tellez-Avila FI, et al. The molecular basis of susceptibility to infection in liver cirrhosis. Curr Med Chem. 2007;14:2954-2958.
7. Perney P, Portalès P, Corbeau P, et al. Specific alteration of peripheral cytotoxic cell perforin expression in alcoholic patients: a possible role in alcohol-related diseases. Alcohol Clin Exp Res. 2003;27:1825-1830.
8. Laso FJ, Madruga JI, Girón JA, et al. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology. 1997;25:1096-1100.
9. Salem TA, El-Refaei MF, Badra GA. Study of antioxidant enzymes level and phagocytic activity in chronic liver disease patients. Egypt J Immunol. 2003;10:37-45.
10. Vargas-Vorackova F, Barbero-Becerra V, Maldonado-Bernal C, et al. Respuesta inflamatoria a productos bacterianos en cirrosis. Rev Gastroenterol Mex. 2006;71(suppl 2):93.
11. Schut ES, de Gans J, van de Beek D. Community-acquired bacterial meningitis in adults. Pract Neurol. 2008;8:8-23.
12. Chang WN, Lu CH, Chang CS, et al. Community-acquired spontaneous bacterial meningitis in patients with alcoholic liver disease. J Formos Med Assoc. 2003;102:653-655.
13. Chang WN, Lu CH, Wu JJ, et al. Community-acquired spontaneous Klebsiella pneumoniae meningitis in adult cirrhotic patients with and without diabetes. Eur J Clin Microbiol Infect Dis. 2003;22:271-273.
14. Cabellos C, Viladrich PF, Ariza J, et al. Community-acquired bacterial meningitis in cirrhotic patients. Clin Microbiol Infect. 2008;14:35-40.
15. Molle I, Thulstrup AM, Svendsen N, et al. Risk and case fatality rate of meningitis in patients with liver cirrhosis. Scand J Infect Dis. 2000;32:407-410.
16. Pauwels A, Pinés E, Aboura M, et al. Bacterial meningitis in cirrhosis: review of 16 cases. J Hepatol. 1997;27:830-834.
17. Toyoda K, Saku Y, Sadoshima S, et al. Purulent meningitis after endoscopic injection sclerotherapy for esophageal varices. Intern Med. 1994;33:706-709.
18. Sheehan GJ, Galbraith JC. Colonoscopy-associated listeriosis: report of a case. Clin Infect Dis. 1993;17:1061-1062.
19. Legrand M, Denis J, Drouhin F, et al. Bacterial meningitis following upper gastrointestinal endoscopy in patients with cirrhosis-bear it in mind. Endoscopy. 2007;39:E96.
20. Liu CE, Jang TN, Wang FD, et al. Invasive group G streptococcal infections: a review of 37 cases. Zhonghua Yi Xue Za Zhi (Taipei). 1995;56:173-178.
21. Nolla-Salas J, Almela M, Gasser I, et al. Spontaneous Listeria monocytogenes peritonitis: a population-based study of 13 cases collected in Spain. Am J Gastroenterol. 2002;97:1507-1511.
22. Yildiz O, Aygen B, Esel D, et al. Sepsis and meningitis due to Listeria monocytogenes. Yonsei Med J. 2007;48:433-439.
23. Suárez MM, Bautista RM, Almela M, et al. Listeria monocytogenes bacteremia: analysis of 110 episodes. Med Clin (Barc). 2007;129:218-221.
24. Artru P, Schleinitz N, Gauzere BA, et al. Neuromeningeal cryptococcosis and alcoholic cirrhosis. Gastroenterol Clin Biol. 1997;21:78-81.
25. Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164-176.
26. Salerno F, Gerbes A, Ginès P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310-1318.
27. Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279-1290.
28. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38:258-266.
29. Cárdenas A, Ginès P. A patient with cirrhosis and increasing creatinine level: what is it and what to do? Clin Gastroenterol Hepatol. 2009;7:1287-1291.
30. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol. 2004;3:30-33.
31. Méndez-Sánchez N, Villa AR, Chávez-Tapia NC, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol. 2005;4:52-55.
32. Méndez-Sánchez N, Almeda-Valdés P, Uribe M. Alcoholic liver disease. An update. Ann Hepatol. 2005;4:32-42.
33. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849-1859. Erratum in: N Engl J Med. 2005;352:950.
34. Du Cheyron D, Bouchet B, Parienti JJ, et al. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med. 2005;31:1693-1699.
35. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology. 2003;37:233-243.
36. Ginès A, Escorsell A, Ginès P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993;105:229-236.
37. Cárdenas A, Ginès P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001;34:671-676.
38. Chen YC, Tsai MH, Hsu CW, et al. Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding. J Nephrol. 2003;16:558-565.
39. Thabut D, Massard J, Gangloff A, et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007;46:1872-1882.
40. Chan CC, Hwang SJ, Lee FY, et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol. 1997;32:942-946.
41. Riordan SM, Skinner N, Nagree A, et al. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology. 2003;37:1154-1164.
42. Ginès P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48:1002-1010.
43. Londoño MC, Cárdenas A, Guevara M, et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut. 2007;56:1283-1290.
44. Leiva JG, Salgado JM, Estradas J, et al. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents. Ann Hepatol. 2007;6:214-221.
45. van de Beek D, Brouwer M, de Gans J. Hypernatremia in bacterial meningitis. J Infect. 2007;55:381-382.
46. Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology. 2005;129:1944-1953.